Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hemab Therapeutics Holdings, Inc. (COAG) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Hemab Therapeutics Holdings, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 2114044.
Total stock buying since 2026: $52,218,142.
Total stock sales since 2026: $0.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 2,840,429 | $52,218,142 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-05 | 2,840,429 | $52,218,142 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-05-06 | Shah Rajeev M. | Buy | 68,018 | 24.30 | 1,652,837 |
| 2026-05-05 | Shah Rajeev M. | Buy | 97,411 | 24.80 | 2,415,305 |
| 2026-05-04 | Shah Rajeev M. | Buy | 2,675,000 | 18.00 | 48,150,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of COAG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hemab Therapeutics Holdings, Inc. (symbol COAG, CIK number 2114044) see the Securities and Exchange Commission (SEC) website.